HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.58

Change

-0.05 (-0.58)%

Market Cap

N/A

Volume

600.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.21 (-0.60%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.01 (-0.03%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.24 (+1.03%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.56 (-1.56%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.67 (+1.49%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

+0.04 (+0.34%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.06 (+0.26%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.89% 87% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.89% 87% B+ 79% B-
Trailing 12 Months  
Capital Gain -3.16% 11% F 19% F
Dividend Return 3.31% 69% C- 57% F
Total Return 0.15% 11% F 19% F
Trailing 5 Years  
Capital Gain 29.02% 34% F 35% F
Dividend Return 46.49% 90% A- 82% B
Total Return 75.51% 48% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 3.48% 50% F 44% F
Dividend Return 4.29% 51% F 41% F
Total Return 0.81% 79% B- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.28% 68% D+ 84% B
Risk Adjusted Return 58.98% 66% D+ 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike